Premium
Drug Development (and Academic Medicine): Charting the Course Forward
Author(s) -
Hohl R J
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2014.171
Subject(s) - clinical pharmacology , drug development , engineering ethics , process (computing) , pharmaceutical industry , medicine , pharmacology , drug , computer science , engineering , operating system
Drug development is both scientifically and economically driven. Past efforts to support the process have had great success, but increasing economic and regulatory pressures again threaten continued progress. The path from discovery to clinical use is in need of reevaluation with regard to substantive changes to reenergize the process. Such reevaluation includes clinical pharmacology input from all in our academia, industry, and regulatory sectors. Clinical Pharmacology & Therapeutics (2014); 96 5, 519–522. doi: 10.1038/clpt.2014.171